Working for those with rare salivary gland cancers.

New Treatment Options in Adenoid Cystic Carcinoma (ACC), Updates from ASCO 2026

29 Jul 2026

Prof Kevin Harrington presents an update on new treatment options for Adenoid Cystic Carcinoma (ACC), shared as part of the ASCO 2026 meeting.

Acinic Cell Carcinoma (AcCC)

Acinic cell carcinomas account for 1-6% of salivary gland tumours.

Carcinosarcoma of the Salivary Glands

Carcinosarcoma accounts for less than 1% of all salivary gland tumours

Mucoepidermoid Carcinoma (MEC) & Warthin-like MEC

Mucoepidermoid Carcinoma (MEC) including Warthin-like MEC

Myoepithelial Carcinoma (MC)

Myoepithelial carcinoma makes up less than 2% of all salivary gland tumours

Polymorphus Adenocarcinoma (PAC)

Polymorphous adenocarcinoma (PAC) accounts for around 12% of malignant salivary gland tumours

Basal Cell Adenocarcinoma (BCAC)

Basal Cell Adenocarcinoma (BCAC) accounts for 1-3% of salivary gland cancers

Clinical Utility of Whole-Genome Sequencing to Aid Histologic Diagnosis and to Direct Personalized Medicine in Salivary Gland Cancer

Whole-Genome Sequencing (WGS) can be achieved in a clinically relevant timeframe for patients with relapsed/metastatic SGC

Salivary Gland Cancer Day - 4th October

19 Dec 2025

Raising Awareness for a Rare Disease. Welcome to the WORLD'S FIRST Salivary Gland Cancer Day, being held annually on the 4th of October.

SGC Travel Grants

Apply for funding to travel to a conference or workshop. We welcome all applications that are aligned with our strategy.

Load more stories